Case Study Download Available

Thank you for completing the form to access our case study library. To access a PDF version of the requested case study, please click the appropriate link below.

Champions TumorGrafts® Guide the Development of a Novel, Selective Dual BRAF/EGFR Inhibitor, CEP-32496

Champions Oncology - Specializing in | Personalized Cancer Therapy | Translational Oncology Solutions | Oncology drug development | Oncology drug discovery | Translational oncology | Translation oncology research | Predictive oncology | Patient-derived xenograft model | Tumorgrafts | Alternative/new cancer treatment | Anticancer therapies | Personalized cancer treatment | Personalized cancer therapy | Personalized oncology